GWM
CVS icon

Graybill Wealth Management’s CVS Health CVS Stock Holding History

Graybill Wealth Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-44,329
Closed -$3.5M – 58
2023
Q4 		$3.5M Sell
44,329
-99
-0.2% -$7.05K 1.55% 34
2023
Q3 		$3.1M Buy
44,428
+1,989
+5% +$141K 1.51% 33
2023
Q2 		$2.93M Buy
42,439
+221
+0.5% +$15.7K 1.39% 35
2023
Q1 		$3.14M Buy
42,218
+1,844
+5% +$155K 1.6% 33
2022
Q4 		$3.76M Buy
40,374
+102
+0.3% +$9.84K 2.04% 24
2022
Q3 		$3.84M Buy
40,272
+937
+2% +$92.7K 2.28% 17
2022
Q2 		$3.65M Sell
39,335
-669
-2% -$65.3K 2.02% 22
2022
Q1 		$4.05M Buy
40,004
+436
+1% +$45.8K 1.97% 27
2021
Q4 		$4.08M Buy
39,568
+109
+0.3% +$10.1K 1.85% 27
2021
Q3 		$3.35M Buy
39,459
+745
+2% +$62.4K 1.65% 31
2021
Q2 		$3.23M Sell
38,714
-117
-0.3% -$9.58K 1.59% 34
2021
Q1 		$2.92M Buy
+38,831
New +$2.83M 1.55% 36

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Graybill Wealth Management's CVS Position: Q1 2024 in Review

Graybill Wealth Management sold out of CVS Health (CVS) in Q1 2024, closing a stake of 44,329 shares — an estimated $3.5M sold.

Graybill Wealth Management first reported a position in CVS in Q1 2021 and held it in 12 quarters. The position peaked at $4.08M in Q4 2021. 2,176 funds tracked by Wall St. Rank hold CVS as of Q1 2024.

  • Graybill Wealth Management reported no remaining CVS Health position as of Q1 2024 after selling out during the quarter.
  • Graybill Wealth Management sold 44,329 CVS Health shares in Q1 2024, an estimated $3.5M.
  • Graybill Wealth Management first reported a position in CVS Health in Q1 2021 and held it in 12 quarters.
  • Graybill Wealth Management's CVS Health position peaked at $4.08M in Q4 2021.
  • 2,176 funds tracked by Wall St. Rank held CVS Health as of Q1 2024.

Based on Graybill Wealth Management's 13F filing for Q1 2024, filed 15 Apr 2024.